A citation-based method for searching scientific literature

Matthias Barton, Matthias R Meyer, Eric R Prossnitz. Steroids 2019
Times Cited: 10







List of co-cited articles
48 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Obligatory role for GPER in cardiovascular aging and disease.
Matthias R Meyer, Natalie C Fredette, Christoph Daniel, Geetanjali Sharma, Kerstin Amann, Jeffrey B Arterburn, Matthias Barton, Eric R Prossnitz. Sci Signal 2016
45
40



G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer.
Atanas Ignatov, Tanja Ignatov, Christine Weissenborn, Holm Eggemann, Joachim Bischoff, Andrzej Semczuk, Albert Roessner, Serban Dan Costa, Thomas Kalinski. Breast Cancer Res Treat 2011
125
20

A transmembrane intracellular estrogen receptor mediates rapid cell signaling.
Chetana M Revankar, Daniel F Cimino, Larry A Sklar, Jeffrey B Arterburn, Eric R Prossnitz. Science 2005
20

The Novel Compound Sul-121 Preserves Endothelial Function and Inhibits Progression of Kidney Damage in Type 2 Diabetes Mellitus in Mice.
S P H Lambooy, A Bidadkosh, D Nakladal, A van Buiten, R A T Girgis, A C van der Graaf, T J Wiedenmann, R A Koster, P Vogelaar, H Buikema,[...]. Sci Rep 2017
8
25


Mitoprotection attenuates myocardial vascular impairment in porcine metabolic syndrome.
Fang Yuan, Ahmad F Hedayat, Christopher M Ferguson, Amir Lerman, Lilach O Lerman, Alfonso Eirin. Am J Physiol Heart Circ Physiol 2018
13
20

The importance of the nitric oxide-cGMP pathway in age-related cardiovascular disease: Focus on phosphodiesterase-1 and soluble guanylate cyclase.
Keivan Golshiri, Ehsan Ataei Ataabadi, Eliana C Portilla Fernandez, A H Jan Danser, Anton J M Roks. Basic Clin Pharmacol Toxicol 2020
17
20


Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
Dick de Zeeuw, Tadao Akizawa, Paul Audhya, George L Bakris, Melanie Chin, Heidi Christ-Schmidt, Angie Goldsberry, Mark Houser, Melissa Krauth, Hiddo J Lambers Heerspink,[...]. N Engl J Med 2013
643
20


Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
William B White, Kenneth G Saag, Michael A Becker, Jeffrey S Borer, Philip B Gorelick, Andrew Whelton, Barbara Hunt, Majin Castillo, Lhanoo Gunawardhana. N Engl J Med 2018
364
20

A Soluble Guanylate Cyclase Activator Inhibits the Progression of Diabetic Nephropathy in the ZSF1 Rat.
Carine M Boustany-Kari, Paul C Harrison, Hongxing Chen, Kathleen A Lincoln, Hu Sheng Qian, Holly Clifford, Hong Wang, Xiaomei Zhang, Kristina Gueneva-Boucheva, Todd Bosanac,[...]. J Pharmacol Exp Ther 2016
34
20

Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor.
Kazufumi Hirano, Woei Shin Chen, Adeline L W Chueng, Angela A Dunne, Tamara Seredenina, Aleksandra Filippova, Sumitra Ramachandran, Angela Bridges, Laiq Chaudry, Gary Pettman,[...]. Antioxid Redox Signal 2015
86
20

The 6-chromanol derivate SUL-109 enables prolonged hypothermic storage of adipose tissue-derived stem cells.
Ghazaleh Hajmousa, Pieter Vogelaar, Linda A Brouwer, Adrianus C van der Graaf, Robert H Henning, Guido Krenning. Biomaterials 2017
21
20

An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension.
John P Hanrahan, Jelena P Seferovic, James D Wakefield, Phebe J Wilson, Jennifer G Chickering, Joon Jung, Kenneth E Carlson, Daniel P Zimmer, Andrew L Frelinger, Alan D Michelson,[...]. Diabetologia 2020
14
20


Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy.
Delyth Graham, Ngan N Huynh, Carlene A Hamilton, Elisabeth Beattie, Robin A J Smith, Helena M Cochemé, Michael P Murphy, Anna F Dominiczak. Hypertension 2009
262
20

Catalytic consumption of nitric oxide by 12/15- lipoxygenase: inhibition of monocyte soluble guanylate cyclase activation.
M J Coffey, R Natarajan, P H Chumley, B Coles, P R Thimmalapura, M Nowell, H Kühn, M J Lewis, B A Freeman, V B O'Donnell. Proc Natl Acad Sci U S A 2001
55
20


Mitoprotection preserves the renal vasculature in porcine metabolic syndrome.
Alfonso Eirin, Ahmad F Hedayat, Christopher M Ferguson, Stephen C Textor, Amir Lerman, Lilach O Lerman. Exp Physiol 2018
14
20

Novel therapeutic strategies in the management of arterial hypertension.
Dimitris Tousoulis, Emmanuel Androulakis, Nikolaos Papageorgiou, Christodoulos Stefanadis. Pharmacol Ther 2012
9
22

A Randomized, Placebo-Controlled, Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Soluble Guanylate Cyclase Stimulator Praliciguat in Healthy Subjects.
John P Hanrahan, James D Wakefield, Phebe J Wilson, Marina Mihova, Jennifer G Chickering, Dennis Ruff, Michael Hall, G Todd Milne, Mark G Currie, Albert T Profy. Clin Pharmacol Drug Dev 2019
16
20

Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction.
Manuel Thieme, Sema H Sivritas, Evanthia Mergia, Sebastian A Potthoff, Guang Yang, Lydia Hering, Katharina Grave, Henning Hoch, Lars C Rump, Johannes Stegbauer. Am J Physiol Renal Physiol 2017
23
20

Oxidation of cysteine 117 stimulates constitutive activation of the type Iα cGMP-dependent protein kinase.
Jessica L Sheehe, Adrian D Bonev, Anna M Schmoker, Bryan A Ballif, Mark T Nelson, Thomas M Moon, Wolfgang R Dostmann. J Biol Chem 2018
25
20

Proof of Principle for a Novel Class of Antihypertensives That Target the Oxidative Activation of PKG Iα (Protein Kinase G Iα).
Joseph R Burgoyne, Oleksandra Prysyazhna, Daniel A Richards, Philip Eaton. Hypertension 2017
18
20

Endothelium-dependent and -independent relaxation and VASP serines 157/239 phosphorylation by cyclic nucleotide-elevating vasodilators in rat aorta.
Andreas Schäfer, Mick Burkhardt, Tobias Vollkommer, Johann Bauersachs, Thomas Münzel, Ulrich Walter, Albert Smolenski. Biochem Pharmacol 2003
46
20

Chronic sildenafil treatment corrects endothelial dysfunction and improves hypertension.
Keila Yaguas, Rocio Bautista, Yasmir Quiroz, Atilio Ferrebuz, Héctor Pons, Martha Franco, Nosratola D Vaziri, Bernardo Rodriguez-Iturbe. Am J Nephrol 2010
25
20

Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension.
Evanthia Mergia, Johannes Stegbauer. Curr Hypertens Rep 2016
25
20

Singlet molecular oxygen regulates vascular tone and blood pressure in inflammation.
Christopher P Stanley, Ghassan J Maghzal, Anita Ayer, Jihan Talib, Andrew M Giltrap, Sudhir Shengule, Kathryn Wolhuter, Yutang Wang, Preet Chadha, Cacang Suarna,[...]. Nature 2019
56
20

Mitochondrial dynamics in adaptive and maladaptive cellular stress responses.
Verónica Eisner, Martin Picard, György Hajnóczky. Nat Cell Biol 2018
245
20

Long-lasting blood pressure lowering effects of nitrite are NO-independent and mediated by hydrogen peroxide, persulfides, and oxidation of protein kinase G1α redox signalling.
Martin Feelisch, Takaaki Akaike, Kayleigh Griffiths, Tomoaki Ida, Oleksandra Prysyazhna, Joanna J Goodwin, Nicholas D Gollop, Bernadette O Fernandez, Magdalena Minnion, Miriam M Cortese-Krott,[...]. Cardiovasc Res 2020
25
20

Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats.
Morten Laursen, Lilliana Beck, Jan Kehler, Claus Tornby Christoffersen, Christoffer Bundgaard, Susie Mogensen, Tomas Joachim Mow, Estéfano Pinilla, Jakob Schöllhammer Knudsen, Elise Røge Hedegaard,[...]. Br J Pharmacol 2017
21
20

Blood Pressure-Lowering by the Antioxidant Resveratrol Is Counterintuitively Mediated by Oxidation of cGMP-Dependent Protein Kinase.
Oleksandra Prysyazhna, Kathryn Wolhuter, Christopher Switzer, Celio Santos, Xiaoping Yang, Steven Lynham, Ajay M Shah, Philip Eaton, Joseph R Burgoyne. Circulation 2019
38
20

Therapeutic targeting of mitochondrial superoxide in hypertension.
Anna E Dikalova, Alfiya T Bikineyeva, Klaudia Budzyn, Rafal R Nazarewicz, Louise McCann, William Lewis, David G Harrison, Sergey I Dikalov. Circ Res 2010
520
20

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
Paul W Armstrong, Burkert Pieske, Kevin J Anstrom, Justin Ezekowitz, Adrian F Hernandez, Javed Butler, Carolyn S P Lam, Piotr Ponikowski, Adriaan A Voors, Gang Jia,[...]. N Engl J Med 2020
387
20

Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced heme.
Edward A Pankey, Manish Bhartiya, Adeleke M Badejo, Umair Haider, Johannes-Peter Stasch, Subramanyam N Murthy, Bobby D Nossaman, Philip J Kadowitz. Am J Physiol Heart Circ Physiol 2011
52
20

Generation and phenotypic characterization of Pde1a mutant mice.
Xiaofang Wang, Satsuki Yamada, Wells B LaRiviere, Hong Ye, Jason L Bakeberg, María V Irazabal, Fouad T Chebib, Jan van Deursen, Peter C Harris, Caroline R Sussman,[...]. PLoS One 2017
19
20

Haemodynamic effects of the selective phosphodiesterase 5 inhibitor, UK-357,903, in conscious SHR.
Sheila M Gardiner, Julie E March, Philip A Kemp, Stephen A Ballard, Ed Hawkeswood, Bernadette Hughes, Terence Bennett. Br J Pharmacol 2004
7
28

The (R)-enantiomer of the 6-chromanol derivate SUL-121 improves renal graft perfusion via antagonism of the α1-adrenoceptor.
D Nakladal, H Buikema, A Reyes Romero, S P H Lambooy, J Bouma, G Krenning, P Vogelaar, A C van der Graaf, M R Groves, J Kyselovic,[...]. Sci Rep 2019
9
22



Mechanisms underlying endothelial dysfunction in diabetes mellitus.
U Hink, H Li, H Mollnau, M Oelze, E Matheis, M Hartmann, M Skatchkov, F Thaiss, R A Stahl, A Warnholtz,[...]. Circ Res 2001
864
20

Nox1/4 inhibition exacerbates age dependent perivascular inflammation and fibrosis in a model of spontaneous hypertension.
R Nosalski, T Mikolajczyk, M Siedlinski, B Saju, J Koziol, P Maffia, T J Guzik. Pharmacol Res 2020
12
20

Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition.
Sven Wind, Knut Beuerlein, Melanie E Armitage, Ashraf Taye, Arun H S Kumar, Daniel Janowitz, Christina Neff, Ajay M Shah, Kirstin Wingler, Harald H H W Schmidt. Hypertension 2010
135
20

NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets.
Yixuan Zhang, Priya Murugesan, Kai Huang, Hua Cai. Nat Rev Cardiol 2020
183
20

NOX1 mediates metabolic heart disease in mice and is upregulated in monocytes of humans with diastolic dysfunction.
Lifen Xu, Melania Balzarolo, Emma L Robinson, Vera Lorenz, Giacomo Della Verde, Lydia Joray, Michika Mochizuki, Beat A Kaufmann, Gideon Valstar, Saskia C A de Jager,[...]. Cardiovasc Res 2022
6
33


Two novel GPER agonists induce gene expression changes and growth effects in cancer cells.
R Lappano, C Rosano, M F Santolla, M Pupo, E M De Francesco, P De Marco, M Ponassi, A Spallarossa, A Ranise, M Maggiolini. Curr Cancer Drug Targets 2012
59
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.